New digital therapeutics startup NuvoAir has closed a financing round of $3 million USD led by venture capital firm Industrifonden. Launched in 2015, NuvoAir created a smartphone-connected “spirometer” that provides real-time lung function assessments at home possible. With air quality deteriorating startups like NuvoAir are seizing on the opportunity to monitor respiratory diseases with apps and smart devices.

Notable Quotes: “This investment and partnership can significantly advance our focus on digital therapeutics and bring to market new smart devices to help patients manage their condition while improving physicians’ clinical decisions.” – Lorenzo Consoli, CEO of NuvoAir